首页> 外文OA文献 >Ranking small molecules by how much they preferentially inhibit the growth of cancer cell lines with either BRAF or KRAS oncogene mutations

【2h】

Ranking small molecules by how much they preferentially inhibit the growth of cancer cell lines with either BRAF or KRAS oncogene mutations

机译：通过将小分子排序，它们优先抑制与BRAF或KRAS癌基因突变的癌细胞系的生长

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
James Langham;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. IRS2 Copy Number Gain, KRAS and BRAF Mutation Status as Predictive Biomarkers for Response to the IGF-1R/IR Inhibitor BMS-754807 in Colorectal Cancer Cell Lines [J] . Huang Fei, Chang Han, Greer Ann, Molecular cancer therapeutics . 2015,第2期

机译：IRS2拷贝数增益，KRAS和BRAF突变状态作为预测IGF-1R / IR抑制剂BMS-754807在大肠癌细胞系中反应的生物标志物
2. Correlation Between PD-L1 22C3 Expression and Oncogene Driver Mutations in EGFR, ALK, KRAS and BRAF in Non-Small Cell Lung Cancer [J] . Nicka C., Memoli V., de Abreu F., The Journal of molecular diagnostics: JMD . 2017,第6期

机译：非小细胞肺癌EGFR，ALK，KRAS和BRAF中PD-L1 22C3表达和癌基因驱动突变的相关性
3. Effects of PHA-665752 and Cetuximab Combination Treatment on In Vitro and Murine Xenograft Growth of Human Colorectal Cancer Cells with KRAS or BRAF Mutations [J] . Jia Yi-Tao, Yang Dong-Hai, Zhao Zhaolong, Current cancer drug targets . 2018,第3期

机译：PHA-665752和西妥昔单抗组合治疗对kras或braf突变的体外癌细胞体外和小鼠异种移植生长的影响
4. Isolation of Circulating Tumor Cells from Patients with Metastatic Colorectal Cancer Using Label-Free Microfluidic Technology for Enumeration and Detection of KRAS, BRAF, PIK3CA Mutation [C] . Haiyan Emily Liu, Evelyn Kidess-Sigal, Melanie Triboulet, International Molecular Medicine Tri-Conference. . 2016

机译：使用无标记微流体技术分离转移性结肠直肠癌患者的循环肿瘤细胞进行募准和检测KRA，BRAF，PIK3CA突变
5. Induction of apoptosis and autophagy by the small molecule inhibitor VMY-1-103 in cancer cell lines and reduction of tumor growth in vivo. [D] . Sirajuddin, Paul. 2013

机译：小分子抑制剂VMY-1-103在癌细胞系中诱导凋亡和自噬，并降低体内肿瘤的生长。
6. Antitumoral Efficacy of the Protease Inhibitor Gabexate Mesilate in Colon Cancer Cells Harbouring KRAS, BRAF and PIK3CA Mutations [O] . Giovanni Brandi, Simona Tavolari, Francesco De Rosa, 2009

机译：蛋白酶抑制剂Gabexate甲磺酸盐在带有KRAS，BRAF和PIK3CA突变的结肠癌细胞中的抗肿瘤功效
7. Ranking small molecules by how much they preferentially inhibit the growth of cancer cell lines with either BRAF or KRAS oncogene mutations [O] . James Langham 2014

机译：通过将小分子排序，它们优先抑制与BRAF或KRAS癌基因突变的癌细胞系的生长

Ranking small molecules by how much they preferentially inhibit the growth of cancer cell lines with either BRAF or KRAS oncogene mutations

著录项

引文网络

相似文献

相关主题

期刊订阅